Longitudinal MRI Temporal Transformer Fusion Model for Predicting Induction Chemotherapy Efficacy in Locally Advanced Nasopharyngeal Carcinoma

Introduction Induction chemotherapy (IC) represents a standard treatment approach for locally advanced nasopharyngeal carcinoma (LA-NPC), yet marked interpatient heterogeneity in treatment response persists. This study sought to develop and evaluate a temporal Transformer–based fusion model integrat...

Full description

Bibliographic Details
Published in:	Technology in Cancer Research & Treatment
Main Authors:	Lei Han, Xiaoyu Chen, Zhengyu Zhao, Yong Liu, Dongyang Yu, Hui Zhang, Fang Ge
Format:	Article
Language:	English
Published:	SAGE Publishing 2026-06-01
Online Access:	https://doi.org/10.1177/15330338261457511

Similar Items

Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
by: Wen-Fei Li, et al.
Published: (2016-11-01)

Comparison of the pre-treatment functional MRI metrics’ efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy
by: Da-wei Zhao, et al.
Published: (2021-11-01)

Prediction of induction chemotherapy efficacy in patients with locally advanced nasopharyngeal carcinoma using habitat subregions derived from multi-modal MRI radiomics
by: Mulan Pan, et al.
Published: (2025-05-01)

A comparative study of functional MRI in predicting response of regional nodes to induction chemotherapy in patients with nasopharyngeal carcinoma
by: Dawei Zhao, et al.
Published: (2022-08-01)

Assessment of Response to Different Induction Chemotherapy Regimens in Locally Advanced Nasopharyngeal Carcinoma
by: Lian CL, et al.
Published: (2023-02-01)

Two or three cycles of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma?
by: Lin-Feng Guo, et al.
Published: (2025-08-01)

Induction chemotherapy in the treatment of nasopharyngeal carcinoma: Clinical outcomes and patterns of care
by: Prashant Gabani, et al.
Published: (2018-08-01)

The Most Efficacious Induction Chemotherapy Regimen for Locoregionally Advanced Nasopharyngeal Carcinoma: A Network Meta-Analysis
by: Horace Cheuk-Wai Choi, et al.
Published: (2021-02-01)

Efficacy of adjuvant chemotherapy/maintenance chemotherapy after induction chemotherapy and concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Experiences of two centers
by: Hao‐Yun Tao, et al.
Published: (2023-03-01)

Efficacy of Chemotherapy in Survival of Stage I Nasopharyngeal Carcinoma
by: Jia-Lin Ma, et al.
Published: (2021-10-01)

Early prediction value of ASL-MRI for induced chemotherapy response and short-term efficacy of locally advanced nasopharyngeal carcinoma
by: SHEN Mingjun, et al.
Published: (2024-09-01)

Metronomic chemotherapy in locoregionally advanced nasopharyngeal carcinoma with residual EBV-DNA after induction chemotherapy
by: Lin-Feng Guo, et al.
Published: (2025-09-01)

The Effects of Different Induction Chemotherapy Cycles and Adjuvant Chemotherapy on the Survival Outcomes of Patients With Locally Advanced Nasopharyngeal Carcinoma
by: Shu Liao, et al.
Published: (2022-06-01)

MRI-based deep learning and radiomics for predicting the efficacy of PD-1 inhibitor combined with induction chemotherapy in advanced nasopharyngeal carcinoma: A prospective cohort study
by: Yiru Wang, et al.
Published: (2025-02-01)

Prediction of induction chemotherapy response in locoregionally advanced nasopharyngeal carcinoma based on three pretreatment non-Gaussian diffusion MRI models
by: Huanhuan Ren, et al.
Published: (2025-07-01)

Optimizing induction chemotherapy regimens for radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
by: Ying Li, et al.
Published: (2023-04-01)

The immune modulation effects of gemcitabine plus cisplatin induction chemotherapy in nasopharyngeal carcinoma
by: Xiao‐Min Li, et al.
Published: (2022-09-01)

PD-1 inhibitor combined with TPF induction chemotherapy in locally advanced nasopharyngeal carcinoma: a retrospective study of efficacy and safety
by: Weiwei Zhang, et al.
Published: (2025-09-01)

Prediction of Response to Induction Chemotherapy Plus Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma Based on MRI Radiomics and Delta Radiomics: A Two-Center Retrospective Study
by: Yuzhen Xi, et al.
Published: (2022-04-01)

Neoadjuvant Chemotherapy in Nasopharyngeal Carcinoma
by: Khudair J. Sabeeh Al-Rawaq
Published: (2012-04-01)

Clinical observation of TPF induction chemotherapy versus PF induction chemotherapy combined with concurrent chemoradiotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma
by: 马雄辉, et al.
Published: (2016-01-01)

Concurrent Chemoradiotherapy With or Without Induction Chemotherapy for Patients with Stage II Nasopharyngeal Carcinoma: An Update
by: Ting Jin, et al.
Published: (2020-01-01)

Effects of induction chemotherapy on nutrition status in locally advanced nasopharyngeal carcinoma: a multicentre prospective study
by: Jingjing Miao, et al.
Published: (2023-04-01)

Additional PD-1 inhibitor improves complete response to induction chemotherapy in locally advanced nasopharyngeal carcinoma
by: Yi-Feng Yu, et al.
Published: (2024-06-01)

The short-term efficacy and safety of induction chemotherapy combined with PD-1 inhibitor or anti-EGFR in locoregionally advanced nasopharyngeal carcinoma
by: Xiaoyong Xiang, et al.
Published: (2023-04-01)

Addition of nimotuzumab to concurrent chemoradiotherapy after induction chemotherapy improves outcomes of patients with locally advanced nasopharyngeal carcinoma
by: Run-Jie Wang, et al.
Published: (2024-03-01)

Efficacy of PD-1 inhibitor plus induction chemotherapy for nasopharyngeal carcinoma with high-grade extranodal extension: a multicenter retrospective analysis
by: Pingting Zhou, et al.
Published: (2026-04-01)

Circulating Microbial Metabolites Predict Tumor Relapse and Chemotherapy Efficacy in Nasopharyngeal Carcinoma
by: Jun‐Yan Li, et al.
Published: (2026-04-01)

Survival after induction chemotherapy in locoregional advanced nasopharyngeal carcinoma: An updated systematic review and meta‐analysis
by: Yiyu Meng, et al.
Published: (2023-10-01)

Individualized induction chemotherapy by pre-treatment plasma Epstein-Barr viral DNA in advanced nasopharyngeal carcinoma
by: Jian Zhang, et al.
Published: (2018-12-01)

Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma
by: Sai-Lan Liu, et al.
Published: (2018-12-01)

Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model
by: Wei Liu, et al.
Published: (2021-05-01)

Immunotherapy plus induction chemotherapy followed by radiotherapy alone or one cycle of concurrent chemotherapy with cisplatin vs induction chemotherapy followed by two cycles of concurrent chemotherapy with cisplatin in locoregionally advanced nasopharyngeal carcinoma
by: Renba Liang, et al.
Published: (2026-05-01)

Long-term outcomes of induction chemotherapy followed by concurrent chemoradiotherapy and adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective study
by: Xiaoyan Zhao, et al.
Published: (2024-11-01)

Concurrent chemotherapy using taxane plus cisplatin cisplatin alone in high-risk nasopharyngeal carcinoma patients with suboptimal response to induction chemotherapy
by: Ya-Ni Zhang, et al.
Published: (2023-06-01)

Induction chemotherapy with paclitaxel, carboplatin and cetuximab for locoregionally advanced nasopharyngeal carcinoma: A single-center, retrospective study
by: Naohiro Takeshita, et al.
Published: (2022-08-01)

Individualized number of induction chemotherapy cycles for locoregionally advanced nasopharyngeal carcinoma patients based on early tumor response
by: Yu‐Ting Jiang, et al.
Published: (2023-02-01)

Deciphering the Prognostic Efficacy of MRI Radiomics in Nasopharyngeal Carcinoma: A Comprehensive Meta-Analysis
by: Chih-Keng Wang, et al.
Published: (2024-04-01)

Novel genetic algorithm‐based individual treatment effect scoring model for optimizing decision‐making: Induction chemotherapy in nasopharyngeal carcinoma
by: Chao Luo, et al.
Published: (2025-10-01)

MRI-based deep learning model predicts distant metastasis and chemotherapy benefit in stage II nasopharyngeal carcinoma
by: Yu-Jun Hu, et al.
Published: (2023-06-01)